Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
Type 2 diabetes (T2D) is a leading cause of death and disability worldwide. It is a chronic metabolic disorder that develops due to an interplay of genetic, lifestyle, and environmental factors. The biological onset of the disease occurs long before clinical symptoms develop, thus the search for ear...
Main Authors: | Tarryn Willmer, Rabia Johnson, Johan Louw, Carmen Pheiffer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2018.00744/full |
Similar Items
-
Corrigendum: Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
by: Tarryn Willmer, et al.
Published: (2019-01-01) -
Ethnic and Adipose Depot Specific Associations Between DNA Methylation and Metabolic Risk
by: Carmen Pheiffer, et al.
Published: (2020-09-01) -
Global and gene-specific DNA methylation in adult type 2 diabetic individuals: a protocol for a systematic review
by: Tinashe Mutize, et al.
Published: (2018-03-01) -
The role of maternal DNA methylation in pregnancies complicated by gestational diabetes
by: Stephanie Dias, et al.
Published: (2022-09-01) -
Association of zinc level with DNA methylation and its consequences: A systematic review
by: Ziauddin Azimi, et al.
Published: (2022-10-01)